| 000 | 01795 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517035551.0 | ||
| 264 | 0 | _c20160815 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1938-0690 | ||
| 024 | 7 |
_a10.1016/j.cllc.2015.05.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBar, Jair | |
| 245 | 0 | 0 |
_aAngiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. _h[electronic resource] |
| 260 |
_bClinical lung cancer _cNov 2015 |
||
| 300 |
_ae189-201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldosterone _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xblood |
| 650 | 0 | 4 | _aCanada |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDing, Keyue | |
| 700 | 1 | _aZhao, Huijun | |
| 700 | 1 | _aHan, Lei | |
| 700 | 1 | _aLaurie, Scott A | |
| 700 | 1 | _aSeymour, Lesley | |
| 700 | 1 | _aAddison, Christina L | |
| 700 | 1 | _aShepherd, Frances A | |
| 700 | 1 | _aGoss, Glenwood D | |
| 700 | 1 | _aDimitroulakos, Jim | |
| 700 | 1 | _aBradbury, Penelope A | |
| 773 | 0 |
_tClinical lung cancer _gvol. 16 _gno. 6 _gp. e189-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cllc.2015.05.002 _zAvailable from publisher's website |
| 999 |
_c24989075 _d24989075 |
||